Abstract

We previously reported a new approach for micromanipulation and encapsulation of human stem cells using a droplet-based microfluidic device. This approach demonstrated the possibility of encapsulating and culturing difficult-to-preserve primary human hematopoietic stem cells using an engineered double-layered bead composed by an inner layer of alginate and an outer layer of Puramatrix. We also demonstrated the maintenance and expansion of Multiple Myeloma cells in this construction. Here, the presented microfluidic technique is applied to construct a 3D biomimetic model to recapitulate the human hematopoietic stem cell niche using double-layered hydrogel beads cultured in 10% FBS culture medium. In this model, the long-term maintenance of the number of cells and expansion of hHSCS encapsulated in the proposed structures was observed. Additionally, a phenotypic characterization of the human hematopoietic stem cells generated in the presented biomimetic model was performed in order to assess their long-term stemness maintenance. Results indicate that the ex vivo cultured human CD34+ cells from bone marrow were viable, maintained, and expanded over a time span of eight weeks. This novel long-term stem cell culture methodology could represent a novel breakthrough to improve Hematopoietic Progenitor cell Transplant (HPT) as well as a novel tool for further study of the biochemical and biophysical factors influencing stem cell behavior. This technology opens a myriad of new applications as a universal stem cell niche model potentially able to expand other types of cells.

Highlights

  • Hematopoietic stem cells (HSCs) are located in the bone marrow and peripheral blood after mobilization and are the source of all blood cells through life [1,2,3]

  • In this study, using the know-how already developed by our group, we report a droplet-based microfluidic platform able to generate double-layered hydrogel beads in a passive manner with tunable hydrogels for long term human hematopoietic stem cell culture

  • A maintained population of CD34+ cells in both singleand double-layered structures was observed after a week, indicating the appropriateness of both Puramatrix and the combined double layer scaffold to allocate human hematopoietic stem cells for a one week cell culture assay

Read more

Summary

Introduction

Hematopoietic stem cells (HSCs) are located in the bone marrow and peripheral blood after mobilization and are the source of all blood cells through life [1,2,3]. Due to their ability to reconstitute the entire cellular compartment of the blood, HSCs are routinely transplanted to treat patients with life-threatening hematological disorders such as leukemia. There is no model that efficiently replicates the in vivo expansion of HSCs allowing cell proliferation while preserving their stem cell properties. When the hematopoietic stem cells are cultured ex vivo, they quickly

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call